Newsfiscal.ai
Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Congress
· Published
Article summary
Anixa Biosciences announced it will present data from its ovarian cancer CAR-T clinical trial at the ESMO Immuno-Oncology & Advanced Therapies Congress 2026.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…